{
    "root": "2f752f08-8460-66e9-e063-6294a90acfcb",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "tamsulosin hydrochloride",
    "value": "20250303",
    "ingredients": [
        {
            "name": "METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A",
            "code": "NX76LV5T8J"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW)",
            "code": "P2OM2Q86BI"
        },
        {
            "name": "TAMSULOSIN HYDROCHLORIDE",
            "code": "11SV1951MR"
        }
    ],
    "indications": "tamsulosin hydrochloride capsules , usp indicated treatment signs symptoms benign prostatic hyperplasia ( bph ) [ ( 14 ) ] . tamsulosin hydrochloride capsules , usp indicated treatment hypertension .",
    "contraindications": "tamsulosin hydrochloride capsule usp , 0.4 mg daily recommended dose treatment signs symptoms bph . administered approximately one-half hour following meal day . tamsulosin hydrochloride capsules , usp crushed , chewed opened . patients fail respond 0.4 mg dose 2 4 weeks dosing , dose tamsulosin hydrochloride capsules , usp increased 0.8 mg daily . tamsulosin hydrochloride capsules , usp 0.4 mg used combination strong inhibitors cyp3a4 ( e.g . , ketoconazole ) [ ( 5.2 ) ] . tamsulosin hydrochloride capsules , usp discontinued interrupted several days either 0.4 mg 0.8 mg dose , therapy started 0.4 mg once-daily dose .",
    "warningsAndPrecautions": "tamsulosin hydrochloride capsules usp , 0.4 mg supplied high density polyethylene bottles containing hard gelatin capsules light green cap yellow body imprinted “ tml 0.4 ” cap body . available : ndc : 70518-1999-00 ndc : 70518-1999-01 ndc : 70518-1999-02 packaging : 28 1 blister pack packaging : 30 1 blister pack packaging : 90 1 bottle plastic store 25°c ( 77°f ) ; excursions permitted 15° 30°c ( 59° 86°f ) [ usp controlled room temperature ] . keep tamsulosin hydrochloride capsules , usp medicines reach children . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "tamsulosin hydrochloride capsules , usp contraindicated patients known hypersensitive tamsulosin hydrochloride component tamsulosin hydrochloride capsules , usp . included skin rash , urticaria , pruritus , angioedema , respiratory symptoms [ ( 6.2 ) ] .",
    "indications_original": "Tamsulosin hydrochloride capsules, USP are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [\n       \n \n  see CLINICAL STUDIES (\n        \n  \n   14)\n       \n \n  ]. Tamsulosin hydrochloride capsules, USP are not indicated for the treatment of hypertension.",
    "contraindications_original": "Tamsulosin hydrochloride capsule USP, 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day. Tamsulosin hydrochloride capsules, USP should not be crushed, chewed or opened.\n                  For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of tamsulosin hydrochloride capsules, USP can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules, USP 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) [see\n       \n \n   WARNINGS AND PRECAUTIONS (\n        \n  \n   5.2)\n                     ]. \n      \n\n \n                  If tamsulosin hydrochloride capsules, USP administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.",
    "warningsAndPrecautions_original": "Tamsulosin hydrochloride capsules USP, 0.4 mg are supplied in high density polyethylene bottles containing hard gelatin capsules with light green cap and yellow body imprinted with “TML 0.4” on cap and body.\n                  Available:\n                  NDC: 70518-1999-00\n                  NDC: 70518-1999-01\n                  NDC: 70518-1999-02\n                  PACKAGING: 28 in 1 BLISTER PACK\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  PACKAGING: 90 in 1 BOTTLE PLASTIC\n                  \n                  \n                  \n                     Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].\n \n                  Keep tamsulosin hydrochloride capsules, USP and all medicines out of reach of children.\n                  \n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Tamsulosin hydrochloride capsules, USP are contraindicated in patients known to be hypersensitive to tamsulosin hydrochloride or any component of tamsulosin hydrochloride capsules, USP. Reactions have included skin rash, urticaria, pruritus, angioedema, and respiratory symptoms [see\n       \n \n   ADVERSE REACTIONS (\n        \n  \n   6.2)\n       \n \n  ]."
}